Thus, overexpressed peroxiredoxin 6 in MCF-7 cancer cells (1.8-fold, Table 1) and PC3 cancer cells (8.5-fold, Table 2) indicates its role in breast and prostate cancer development. This evidence concerns the gene PRDX6 and prostate cancer.